UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		12,497,770
Beginning balance at Dec. 31, 2023	$ 280,315	$ 12	$ 4,425,104	$ (4,144,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	111		111
Issuance of restricted common stock (in shares)		48,918
Repurchases of common stock in open market (in shares)		(58,298)
Repurchases of common stock in open market	(999)		(999)
Forfeiture of unvested restricted stock (in shares)		(6,446)
Net income	468			468
Ending balance (in shares) at Mar. 31, 2024		12,481,944
Ending balance at Mar. 31, 2024	279,895	$ 12	4,424,216	(4,144,333)
Beginning balance (in shares) at Dec. 31, 2023		12,497,770
Beginning balance at Dec. 31, 2023	280,315	$ 12	4,425,104	(4,144,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,148
Ending balance (in shares) at Jun. 30, 2024		12,447,195
Ending balance at Jun. 30, 2024	282,831	$ 12	4,423,472	(4,140,653)
Beginning balance (in shares) at Mar. 31, 2024		12,481,944
Beginning balance at Mar. 31, 2024	279,895	$ 12	4,424,216	(4,144,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	249		249
Issuance of restricted common stock (in shares)		17,323
Repurchases of common stock in open market (in shares)		(54,667)
Repurchases of common stock in open market	(950)		(950)
Net settlement for employee taxes on stock options	(43)		(43)
Stock options exercised, net (in shares)		2,595
Net income	3,680			3,680
Ending balance (in shares) at Jun. 30, 2024		12,447,195
Ending balance at Jun. 30, 2024	$ 282,831	$ 12	4,423,472	(4,140,653)
Beginning balance (in shares) at Dec. 31, 2024	12,213,599	12,213,599
Beginning balance at Dec. 31, 2024	$ 288,690	$ 12	4,419,991	(4,131,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	307		307
Issuance of restricted common stock (in shares)		61,260
Repurchases of common stock in open market (in shares)		(52,337)
Repurchases of common stock in open market	(867)		(867)
Net income	4,539			4,539
Ending balance (in shares) at Mar. 31, 2025		12,222,522
Ending balance at Mar. 31, 2025	$ 292,669	$ 12	4,419,431	(4,126,774)
Beginning balance (in shares) at Dec. 31, 2024	12,213,599	12,213,599
Beginning balance at Dec. 31, 2024	$ 288,690	$ 12	4,419,991	(4,131,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 8,075
Ending balance (in shares) at Jun. 30, 2025	12,183,906	12,183,906
Ending balance at Jun. 30, 2025	$ 246,469	$ 12	4,418,773	(4,172,316)
Beginning balance (in shares) at Mar. 31, 2025		12,222,522
Beginning balance at Mar. 31, 2025	292,669	$ 12	4,419,431	(4,126,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	301		301
Issuance of restricted common stock (in shares)		11,574
Repurchases of common stock in open market (in shares)		(58,954)
Repurchases of common stock in open market	(870)		(870)
Cash dividends	(49,078)			(49,078)
Net settlement for employee taxes on stock options	(89)		(89)
Stock options exercised, net (in shares)		8,764
Net income	$ 3,536			3,536
Ending balance (in shares) at Jun. 30, 2025	12,183,906	12,183,906
Ending balance at Jun. 30, 2025	$ 246,469	$ 12	$ 4,418,773	$ (4,172,316)